chr7-71335562-C-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_022479.3(GALNT17):c.251C>T(p.Ser84Phe) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000106 in 1,597,898 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000072 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000042 ( 0 hom. )
Consequence
GALNT17
NM_022479.3 missense
NM_022479.3 missense
Scores
4
9
5
Clinical Significance
Conservation
PhyloP100: 7.39
Genes affected
GALNT17 (HGNC:16347): (polypeptide N-acetylgalactosaminyltransferase 17) This gene encodes an N-acetylgalactosaminyltransferase. This gene is located centromeric to the common deleted region in Williams-Beuren syndrome (WBS), a multisystem developmental disorder caused by the deletion of contiguous genes at 7q11.23. This protein may play a role in membrane trafficking. [provided by RefSeq, Jan 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GALNT17 | NM_022479.3 | c.251C>T | p.Ser84Phe | missense_variant | 2/11 | ENST00000333538.10 | NP_071924.1 | |
GALNT17 | XM_011516467.4 | c.251C>T | p.Ser84Phe | missense_variant | 2/10 | XP_011514769.1 | ||
GALNT17 | XM_017012521.3 | c.251C>T | p.Ser84Phe | missense_variant | 2/7 | XP_016868010.1 | ||
GALNT17 | XM_011516469.4 | c.251C>T | p.Ser84Phe | missense_variant | 2/6 | XP_011514771.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GALNT17 | ENST00000333538.10 | c.251C>T | p.Ser84Phe | missense_variant | 2/11 | 1 | NM_022479.3 | ENSP00000329654.5 | ||
GALNT17 | ENST00000447516.5 | c.185C>T | p.Ser62Phe | missense_variant | 2/4 | 4 | ENSP00000392019.1 | |||
GALNT17 | ENST00000467723.1 | n.185C>T | non_coding_transcript_exon_variant | 2/11 | 2 | |||||
GALNT17 | ENST00000498380.6 | n.653C>T | non_coding_transcript_exon_variant | 2/11 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152116Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
11
AN:
152116
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000844 AC: 2AN: 236922Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 128512
GnomAD3 exomes
AF:
AC:
2
AN:
236922
Hom.:
AF XY:
AC XY:
0
AN XY:
128512
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000415 AC: 6AN: 1445782Hom.: 0 Cov.: 31 AF XY: 0.00000278 AC XY: 2AN XY: 719178
GnomAD4 exome
AF:
AC:
6
AN:
1445782
Hom.:
Cov.:
31
AF XY:
AC XY:
2
AN XY:
719178
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152116Hom.: 0 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74294
GnomAD4 genome
AF:
AC:
11
AN:
152116
Hom.:
Cov.:
32
AF XY:
AC XY:
5
AN XY:
74294
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 15, 2023 | The c.251C>T (p.S84F) alteration is located in exon 2 (coding exon 2) of the WBSCR17 gene. This alteration results from a C to T substitution at nucleotide position 251, causing the serine (S) at amino acid position 84 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T;.;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D;D
M_CAP
Benign
D
MetaRNN
Uncertain
D;D;D
MetaSVM
Benign
T
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
D;N;.
REVEL
Uncertain
Sift
Benign
D;D;.
Sift4G
Uncertain
D;D;D
Polyphen
D;.;.
Vest4
MutPred
Loss of disorder (P = 0.0185);.;.;
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at